High-Intensity Laser Therapy for Greater Trochanteric Pain Syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effect of high-intensity laser therapy (HILT) versus a sham laser in adults with GTPS of at least 3 months' duration. It measures changes in pain intensity, functional status, and quality of life to determine whether HILT provides meaningful benefit beyond placebo. Participants are adults aged 18 to 80 with confirmed GTPS and a baseline pain score of 4 or higher on the visual analog scale. Exclusion criteria include conditions that could confound results or pose safety risks with laser therapy or physical activity. The trial is conducted at Etlik City Hospital in Ankara, sponsored by Ankara Etlik City Hospital, with no additional collaborators listed.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18 to 80 years
* Patients diagnosed with Greater Trochanteric Pain Syndrome (GTPS) based on clinical examination
* Presence of symptoms for at least 3 months
* Pain intensity ≥4 on the Visual Analog Scale (VAS)
* No corticosteroid injection or other conservative treatment within the last 3 months

Exclusion Criteria:

* Hip fracture, tumor, infection, or advanced osteoarthritis
* Contraindications to high-intensity laser therapy (e.g., pacemaker, pregnancy, coagulation disorders, anticoagulant therapy, neoplasia, history of epilepsy)
* Contraindications to physical activity (e.g., ischemic heart disease, arrhythmia, uncontrolled hypertension, heart failure, severe respiratory insufficiency)
* Peripheral vascular disorders (e.g., thrombophlebitis, thrombosis, lymphedema)
* History of trauma within the last 3 months or prior surgery involving the lower extremity or lumbar spine
* Neurological disorders or chronic inflammatory diseases

Where it's running

• Etlik City Hospital
  Ankara, Yenimahalle, Turkey (Türkiye) Recruiting

Study contacts

• Principal investigator: Gizem Suna Tuncer, MD, Specialist Physician — Ankara Etlik City Hospital
• Study coordinator: Gizem Suna Tuncer, MD, Specialist Physician
• Email: sunagizem05@gmail.com
• Phone: +905347953185

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ReneuRx for lateral hip pain: a treatment option for people with GTPS

  This study tests whether the ReneuRx device can relieve moderate to severe lateral hip pain in adults compared with a corticosteroid injection.

  Recruiting at 7 sites Brixton Biosciences, Inc. · Sun City, Arizona and 10 other locations · NCT07568015

• ESWT versus conventional physical therapy for Greater Trochanteric Pain Syndrome

  This trial will try Extracorporeal Shockwave Therapy (ESWT) against usual physical therapy to see which reduces pain and improves function in adults with Greater Trochanteric Pain Syndrome.

  Recruiting Kanuni Sultan Suleyman Training and Research Hospital · Istanbul · NCT07243327

• Exercise and education program for lateral hip pain

  This study is testing whether a special exercise program and education can help people with lateral hip pain feel better after 12 weeks of treatment.

  Recruiting Horsens Hospital · Horsens, Horsens · NCT06418217

• Evaluating TENEX for hip pain relief

  This study is testing if a special ultrasound-guided procedure called TENEX can help people with chronic hip pain feel better and move easier when other treatments haven't worked.

  Recruiting Montefiore Medical Center · The Bronx, New York · NCT05710627

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.